Pfizer's Weight-Loss Data Just Upends Investor Bets
Pfizer is stepping into a high-stakes arena long led by Lilly and Novo Nordisk. This article analyzes what pfizer's w...
Knowing the right time to start planning for retirement is essential. Discover the best age to begin securing your financial future.
26,342 articlesPfizer is stepping into a high-stakes arena long led by Lilly and Novo Nordisk. This article analyzes what pfizer's w...
Cava Group bets on fresh growth and better margins, even as the market stays wary. This piece breaks down what could ...
As AI expands, the backbone assets—storage, memory, and data-center hardware—could power surprising gains. This artic...
The trucking sector moves in tight cycles, and this week Knight-Swift Transportation faced a sharp price swing. Learn...
A trusted case worker exploited access to SNAP accounts, highlighting insider risk in public benefits. Learn how such...
When a tech giant moves its earnings date early, it often reveals more about where money is flowing than the numbers....
A real-world hotel-charge fraud case highlights how easy it is for card data to be misused. This practical guide show...
A prominent fund has taken a sizable stake in Kirby Corporation, with eyes on a bold earnings target of $6.33 per sha...
Memory prices and AI data demands have put Micron and Sandisk in the spotlight. This piece breaks down what’s driving...
When a growth stock plunges by half, investors often panic. But a durable business model, strong margins, and a clear...
Lilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
A high-profile move by a Palantir insider is sparking debate about valuations, AI stock exposure, and the road ahead ...